BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Breast Cancer
,
Prostate
,
Nosology
,
Prozac
,
rs7903146
,
BRAF
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Zolpidem Tartrate
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Sublingual zolpidem tartrate lozenge for the treatment of insomnia.
Use of partial AUC to demonstrate bioequivalence of Zolpidem Tartrate Extended Release formulations.
Zolpidem tartrate.
A Rapid and Highly Sensitive UPLC-MS-MS Method for the Quantification of Zolpidem Tartrate in Human …
Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middl…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets
Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Zolpidem Tartrate Tablets Under Fed Conditions
Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ